Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Contingent Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹800 Cr₹1,063 Cr₹337 Cr₹361 Cr₹384 Cr

What is the latest Contingent Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Contingent Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹800 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹800 Cr
Mar2024₹1,063 Cr
Mar2023₹337 Cr
Mar2022₹361 Cr
Mar2021₹384 Cr

How is Contingent Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Contingent Liabilities % Change
Mar2025 ₹800 Cr
-24.74
Mar2024 ₹1,063 Cr
215.81
Mar2023 ₹337 Cr
-6.81
Mar2022 ₹361 Cr
-5.96
Mar2021 ₹384 Cr -

Compare Contingent Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹56,469.6 Cr 3.5% -0.9% 31.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,323.0 Cr 1.7% -5.7% -7.4% Stock Analytics
DIVIS LABORATORIES ₹160,825.0 Cr 0.8% -6.7% 3.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,349.0 Cr 0.6% 4.3% 24.4% Stock Analytics
CIPLA ₹106,048.0 Cr -4.7% -12.3% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,494.0 Cr 6.3% -2.1% -4.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.5%

-0.9%

31.4%

SENSEX

-1.7%

-4.3%

6.2%


You may also like the below Video Courses